G01N 2800/7066
Metabolic pathways
G01N2800/7066 (Metabolic pathways) appears on 53 US grants and 126 published applications in this corpus.
Search patents in G01N- Granted patents
- 53
- Published applications
- 126
- Assignees
- 86
- Inventors
- 260
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 0 | 6 |
| 2015 | 2 | 9 |
| 2016 | 1 | 13 |
| 2017 | 5 | 13 |
| 2018 | 5 | 18 |
| 2019 | 12 | 13 |
| 2020 | 12 | 13 |
| 2021 | 7 | 8 |
| 2022 | 3 | 9 |
| 2023 | 3 | 9 |
| 2024 | 0 | 3 |
| 2025 | 1 | 5 |
| 2026 | 2 | 3 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and systems for determining metabolic poise and capacity of living cells11 Aug 2026US 12,704,502 B2Agilent Technologies, Inc.
- Apparatus for analysis of eggs17 Feb 2026US 12,553,879 B2Viscon Group Holding B.V.
- System and method for assessing cellular metabolic activity1 Jul 2025US 12,345,644 B2Trustees of Tufts College
- Electrochemical strips for monitoring the degradation of body fat and method for preparing same18 Apr 2023US 11,629,369 B2Lsee
- Mass spectrometry assay method for detection and quantitation of kidney function metabolites4 Apr 2023US 11,619,636 B2Metabolon, Inc.
- Pulse Stable Tracer Methods for Detection of Short-Chain Fatty Acids12 Mar 2026US 2026/0072044 A1The Texas A&M University System
- Method for measuring mineralocorticoid receptor activity26 Feb 2026US 2026/0056212 A1Osaka University
- Kit for early diagnosis and monitoring of tumors1 Jan 2026US 2026/0002938 A1Romano Laboratory Srls
- Multiplexing homocysteine and cysteine in first-tier screening assays28 Aug 2025US 2025/0271447 A1
- Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions17 Jul 2025US 2025/0228883 A1Empirico Inc.
Most cited
By later US patents
- Dynamic data-driven biological state analysis22US 10,319,477 B1Virta Health Corp. · 2019
- Methods of using variants of FGF19 polypeptides for the treatment of cancer9US 10,369,199 B2NGM Biopharmaceuticals, Inc. · 2019
- Biochemical markers of red blood cell storage and toxicity7US 9,903,876 B2Bloodworks · 2018
- Dynamic data-driven biological state analysis4US 11,538,587 B2Virta Health Corp. · 2022
- Detection of oligosaccharides4US 9,029,530 B2Biomarin Pharmaceutical Inc. · 2015